Royal Bank of Canada
LENZ

Royal Bank of Canada’s LENZ Therapeutics LENZ Stock Holding History

Royal Bank of Canada’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$870K Buy
95,235
+52,063
+121% +$731K ﹤0.01% 3728
2025
Q4 		$691K Sell
43,172
-5,111
-11% -$149K ﹤0.01% 3923
2025
Q3 		$2.25M Buy
48,283
+21,157
+78% +$778K ﹤0.01% 3308
2025
Q2 		$795K Buy
27,126
+26,320
+3,266% +$716K ﹤0.01% 4094
2025
Q1 		$21K Sell
806
-924
-53% -$22.8K ﹤0.01% 5918
2024
Q4 		$50K Buy
1,730
+440
+34% +$13.4K ﹤0.01% 5704
2024
Q3 		$30K Sell
1,290
-52
-4% -$1.15K ﹤0.01% 5944
2024
Q2 		$23K Buy
1,342
+1,249
+1,343% +$21.8K ﹤0.01% 6023
2024
Q1 		$2K Sell
93
-1,003
-92% -$20.8K ﹤0.01% 6719
2023
Q4 		$20K Buy
1,096
+139
+15% +$2.29K ﹤0.01% 6318
2023
Q3 		$17K Sell
957
-203
-18% -$3.53K ﹤0.01% 6246
2023
Q2 		$21K Buy
1,160
+1,159
+115,900% +$23.2K ﹤0.01% 6196
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7569
2022
Q4 		$0 Buy
+1
New +$23 ﹤0.01% 7808
2022
Q2 		– Sell
-259
Closed -$9K – 7779
2022
Q1 		$9K Sell
259
-193
-43% -$12.1K ﹤0.01% 7013
2021
Q4 		$39K Buy
452
+178
+65% +$14.7K ﹤0.01% 6513
2021
Q3 		$32K Buy
274
+269
+5,380% +$39.8K ﹤0.01% 6430
2021
Q2 		$1K Buy
+5
New +$871 ﹤0.01% 7355

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Royal Bank of Canada's LENZ Position: Q1 2026 in Review

Royal Bank of Canada increased its LENZ Therapeutics (LENZ) stake by 121% in Q1 2026, buying an estimated $731K and bringing the position to 95,235 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.

Royal Bank of Canada first reported a position in LENZ in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.25M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Royal Bank of Canada held 95,235 shares of LENZ Therapeutics worth $870K as of Q1 2026.
  • Royal Bank of Canada bought 52,063 LENZ Therapeutics shares in Q1 2026, an estimated $731K.
  • LENZ Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3728 holding.
  • Royal Bank of Canada first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Royal Bank of Canada's LENZ Therapeutics position peaked at $2.25M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.